This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Werbowetski-Ogilvie, T. E. Articles by Del Maestro, R. F. Search for Related Content PubMed PubMed Citation Articles by Werbowetski-Ogilvie, T. E. Articles by Del Maestro, R. F.

Isolation of a Natural Inhibitor of Human Malignant Glial Cell Invasion: Inter -Trypsin Inhibitor Heavy Chain 2

¹ Brain Tumour Research Centre and ² Neuroimmunology Unit, Montreal Neurological Institute, McGill University and ³ Department of Pediatrics, Montreal Children's Hospital Research Institute, Montreal, Quebec, Canada

Requests for reprints: Rolando Del Maestro, Brain Tumour Research Centre, Montreal Neurological Institute and Hospital, 3801 Rue University, Montreal, Quebec, Canada H3A 2B4. Phone: 514-398-5791; Fax: 514-398-2811; E-mail: rolando.delmaestro{at}mcgill.ca.

Malignant central nervous system (CNS) tumors, such as glioblastoma multiforme, invade the brain and disrupt normal tissue architecture, making complete surgical removal virtually impossible. Here, we have developed and optimized a purification strategy to isolate and identify natural inhibitors of glioma cell invasion in a three-dimensional collagen type I matrix. Inter -trypsin inhibitor heavy chain 2 (ITI H2) was identified from the most inhibitory fractions and its presence was confirmed both as a single protein and in a bikunin-bound form. Stable overexpression in U251 glioma cells validated ITI H2's strong inhibition of human glioma cell invasion together with significant inhibition of cell proliferation and promotion of cell-cell adhesion. Analysis of primary human brain tumors showed significantly higher levels of ITI H2 in normal brain and low-grade tumors compared with high-grade gliomas, indicating an inverse correlation with malignancy. The phosphatidylinositol 3-kinase/Akt signaling cascade seemed to be one of the pathways involved in the effect of ITI H2 on U251 cells. These findings suggest that reduction of ITI H2 expression correlates with brain tumor progression and that targeting factors responsible for its loss or restoring the ITI supply exogenously may serve as potential therapeutic strategies for a variety of CNS tumors. (Cancer Res 2006; 66(3): 1464-72)

This article has been cited by other articles:

				T. Demuth, L. B. Reavie, J. L. Rennert, M. Nakada, S. Nakada, D. B. Hoelzinger, C. E. Beaudry, A. N. Henrichs, E. M. Anderson, and M. E. Berens MAP-ing glioma invasion: Mitogen-activated protein kinase kinase 3 and p38 drive glioma invasion and progression and predict patient survival Mol. Cancer Ther., April 1, 2007; 6(4): 1212 - 1222. [Abstract] [Full Text] [PDF]